Early dynamics of viremia in patients with genotype 1b chronic hepatitis C: Peg-IFNalpha2a shows earlier viral decline than peg-IFNalpha2b in combination therapy with ribavirin-Reference-Cited by-同舟云学术

Early dynamics of viremia in patients with genotype 1b chronic hepatitis C: Peg-IFNalpha2a shows earlier viral decline than peg-IFNalpha2b in combination therapy with ribavirin

Published:2011 Issue:12 Volume:17 Page:CR687-CR691
ISSN:1234-1010
Container-title:Medical Science Monitor
language:en
Short-container-title:Med Sci Monit

Author:

Fujino Tatsuya¹,Nakamuta Makoto²,Aoyagi Yoko²,Kohjima Motoyuki²,Satoh Takeaki³,Fukuda Mika¹,Ishibashi Hiromi¹,Yatsuhashi Hiroshi⁴,Enjoji Munechika⁵

Affiliation:

1. Clinical Research Center, National Hospital Organization Nagasaki Medical Center, Nagasaki, Japan

2. Clinical Research Center, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan

3. Center for Liver Diseases, National Hospital Organization Kokura Medical Center, Kitakyushu, Japan

4. Clinical Research Center, National Hospital Organization Nagasaki Medical Center

5. Clinical Research Center, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan and Health Care Center Clinic, Fukuoka University, Fukuoka, Japan

Publisher

International Scientific Information, Inc.

Subject

General Medicine

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viability of pegIFNα-RBV for CHC in the direct acting antiviral era: a practical algorithm between efficacy and cost containment;Journal of Chemotherapy;2016-06-28

2. Differential Antiviral Effects of Pegylated Interferon-α2a and Pegylated Interferon-α2b in Chronic Hepatitis C;Clinical Drug Investigation;2014-10-28

3. Multicenter comparison of PEG-IFN α2a or α2b plus ribavirin for treatment-naïve HCV patient in Korean population;BMC Gastroenterology;2013-04-29